Bessemer Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6K | Buy |
356
+127
| +55% | +$2.14K | ﹤0.01% | 1987 |
|
|
2025
Q1 | $15K | Buy |
229
+54
| +31% | +$3.54K | ﹤0.01% | 1632 |
|
|
2024
Q4 | $21K | Buy |
175
+113
| +182% | +$13.6K | ﹤0.01% | 1511 |
|
|
2024
Q3 | $8K | Buy |
+62
| New | +$8K | ﹤0.01% | 1764 |
|
|
2022
Q3 | – | Sell |
-11
| Closed | -$1K | – | 2161 |
|
|
2022
Q2 | $1K | Sell |
11
-88
| -89% | -$8K | ﹤0.01% | 1835 |
|
|
2022
Q1 | $8K | Hold |
99
| – | – | ﹤0.01% | 1438 |
|
|
2021
Q4 | $9K | Hold |
99
| – | – | ﹤0.01% | 1453 |
|
|
2021
Q3 | $9K | Sell |
99
-5
| -5% | -$455 | ﹤0.01% | 1417 |
|
|
2021
Q2 | $8K | Hold |
104
| – | – | ﹤0.01% | 1380 |
|
|
2021
Q1 | $8K | Buy |
104
+97
| +1,386% | +$7.46K | ﹤0.01% | 1350 |
|
|
2020
Q4 | $2K | Sell |
7
-34
| -83% | -$9.71K | ﹤0.01% | 1433 |
|
|
2020
Q3 | $6K | Sell |
41
-241,062
| -100% | -$35.3M | ﹤0.01% | 1179 |
|
|
2020
Q2 | $38.7M | Buy |
241,103
+7
| +0% | +$1.12K | 0.12% | 153 |
|
|
2020
Q1 | $23.6M | Hold |
241,096
| – | – | 0.1% | 167 |
|
|
2019
Q4 | $31.1M | Buy |
+241,096
| New | +$31.1M | 0.1% | 177 |
|
|
2019
Q3 | – | Sell |
-218,644
| Closed | -$33.2M | – | 1859 |
|
|
2019
Q2 | $33.2M | Buy |
218,644
+218,587
| +383,486% | +$33.2M | 0.11% | 175 |
|
|
2019
Q1 | $7K | Sell |
57
-1,609
| -97% | -$198K | ﹤0.01% | 1553 |
|
|
2018
Q4 | $183K | Buy |
1,666
+1,643
| +7,143% | +$180K | ﹤0.01% | 1001 |
|
|
2018
Q3 | $4K | Buy |
+23
| New | +$4K | ﹤0.01% | 1720 |
|
|
2018
Q1 | – | Sell |
-1,000
| Closed | -$56K | – | 1785 |
|
|
2017
Q4 | $56K | Buy |
+1,000
| New | +$56K | ﹤0.01% | 1239 |
|